A three-dimensional microenvironment alters protein expression and chemosensitivity of epithelial ovarian cancer

Janet Myungjin Lee1, Paulette Mhawech-Fauceglia, Nathan Lee

  • 1Department of Preventive Medicine, University of Southern California/Keck School of Medicine, Los Angeles, CA 90033, USA.

Insights

Three-dimensional (3D) cell cultures better mimic ovarian cancer tumors than 2D models. These 3D models show improved histological features and altered chemoresponse, impacting drug development for epithelial ovarian cancer (EOC).

Area of Science:

  • Oncology
  • Biotechnology
  • Cell Biology

Background:

  • Developing effective cancer therapies is challenging, with many drugs failing to translate from in vitro to clinical success.
  • Replicating the complex in vivo tumor microenvironment in vitro is crucial for improving drug development pipelines.
  • Three-dimensional (3D) cell culture models offer a potential solution to better mimic in vivo conditions compared to traditional two-dimensional (2D) cultures.

Purpose of the Study:

  • To establish and characterize 3D in vitro models for 31 epithelial ovarian cancer (EOC) cell lines.
  • To compare the biological and molecular features of 3D EOC models with 2D cultures and primary tumors.
  • To evaluate the efficacy of 3D EOC models in predicting chemoresponse.

Main Methods:

  • Development of 3D in vitro models using polyhydroxoethylmethacrylate-coated plastics for 31 EOC cell lines.
  • Classification of 3D multicellular aggregates based on size, light permeability, and cellular structure.
  • Comparative analysis of histological differentiation, biomarker expression, proliferation rates, and chemoresistance between 2D and 3D cultures, and primary tumors.

Main Results:

  • 3D EOC models restored histological differentiation features absent in 2D cultures.
  • Transition to 3D culture induced changes in biomarker expression relevant to EOC.
  • EOC cell lines in 3D culture exhibited slower proliferation and increased chemoresistance compared to 2D cultures.

Conclusions:

  • 3D EOC models more accurately reflect the histological, biological, and molecular characteristics of primary tumors than 2D models.
  • 3D in vitro models demonstrate differential sensitivities to chemotherapeutic agents, impacting drug testing efficacy for EOC.
  • These findings suggest that 3D cell culture approaches could significantly improve drug development strategies for epithelial ovarian cancer and other solid tumors.